这份警告强调所有年龄段服用抗抑郁药物的患者都应该得到密切注意，特别是在治疗开始的几周。
The warning emphasizes that patients of all ages taking antidepressants should be closely monitored, especially during the initial weeks of treatment.
这一风险最初是由服用帕罗西汀的患者父母报告的，但是FDA却决定在2004年强制所有抗抑郁药物添加自杀警告，包括三环类药物。
This risk was initially reported in patients using paroxetine, but the FDA decided in 2004 to mandate the warning on suicidality for all antidepressants, including tricyclics.
这一风险最初是由服用帕罗西汀的患者父母报告的，但是FDA却决定在2004年强制所有抗抑郁药物添加自杀警告，包括三环类药物。
This risk was initially reported in patients using paroxetine, but the FDA decided in 2004 to mandate the warning on suicidality for all antidepressants, including tricyclics.
应用推荐